IL6 and Parkinson disease: Consistent with the previous data discussing the elevated levels of IL-6 in the CSF in patients with Parkinson’s disease, it can be concluded that our observations could be potentially related to the occurrence of a non-specific compensatory mechanism which promotes a neuroregenerative phenotype [61].